Takahiro Niimura
Impact in
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Oncology 14
- Cancer Immunotherapy and Biomarkers 6
- Cancer Treatment and Pharmacology 3
- Co-authors
- Yoshito Zamami (55 shared papers)Keisuke Ishizawa (55 shared papers)Yuki Izawa‐Ishizawa (33 shared papers)Naoto Okada (11 shared papers)Mitsuhiro Goda (44 shared papers)Keijo Fukushima (4 shared papers)Toshihiro Koyama (13 shared papers)Hirofumi Hamano (32 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (4 papers)Clinical and Translational Science (4 papers)Frontiers in Pharmacology (4 papers)European Journal of Pharmacology (3 papers)The Journal of Medical Investigation (3 papers)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Takahiro Niimura
57 papers receiving 551 citations
Peers
Comparison fields: 5 of 76
- Toxicology 30
- Oncology 187
- Cardiology and Cardiovascular Medicine 65
- Pulmonary and Respiratory Medicine 89
- Hematology 28
Countries citing papers authored by Takahiro Niimura
This map shows the geographic impact of Takahiro Niimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Niimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Niimura more than expected).
Fields of papers citing papers by Takahiro Niimura
This network shows the impact of papers produced by Takahiro Niimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Niimura. The network helps show where Takahiro Niimura may publish in the future.
Co-authors
The 25 scholars most cited alongside Takahiro Niimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 102 | |
| 2 | 2021 | 68 | |
| 3 | 2020 | 34 | |
| 4 | 2019 | 28 | |
| 5 | 2022 | 23 | |
| 6 | 2020 | 21 | |
| 7 | 2021 | 20 | |
| 8 | 2018 | 17 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 13 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2022 | 12 | |
| 16 | 2024 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2024 | 8 | |
| 20 | 2020 | 8 |
About Takahiro Niimura
Takahiro Niimura is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine, Surgery and Hematology, having authored 69 papers that have together received 556 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Epilepsy research and treatment (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Cancer Treatment and Pharmacology (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). The work is most often cited by research in Toxicology (30 citations), Oncology (187 citations), Cardiology and Cardiovascular Medicine (65 citations), Pulmonary and Respiratory Medicine (89 citations) and Hematology (28 citations). Takahiro Niimura has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Yoshito Zamami, Keisuke Ishizawa, Yuki Izawa‐Ishizawa, Naoto Okada, Mitsuhiro Goda, Keijo Fukushima, Toshihiro Koyama, Hirofumi Hamano, Kenta Yagi and Masayuki Chuma. Their work appears in journals such as Biomedicine & Pharmacotherapy, Clinical and Translational Science, Frontiers in Pharmacology, European Journal of Pharmacology and The Journal of Medical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.